Wyniki wyszukiwania:

Metalloanticancer drug discovery remains one of the progressive areas driving pharmaceutical research. The wide assortment of coordination numbers and geometries, accessible redox states, thermodynamic and kinetic characteristics, and the intrinsic properties of metal ion and ligand offer the medicinal chemist a large diversity of reactivities to be exploited.The modern era of metal-based anticancer drugs began with the discovery of cisplatin by Barnett Rosenberg in the 1960s. The widespread success of metallodrug cisplatin enticed a veritable army of inorganic chemists to search for other...